12/2019 Our collaboration paper with Houghton lab is accepted to Cancer Chemotherapy and Pharmacology.

We show in this paper that mutations in TP53BP1 predict tumor responses to PLX038A, an active metabolite of irinotecan. This is our first collaboration paper with the Houghton lab. Congratulations to Qilin who took on this analysis!